CHESTGuidelines & Topic CollectionsRespiratory Syncytial Virus (RSV): Measuring the Impact and Vaccine Prevention

Respiratory Syncytial Virus (RSV): Measuring the Impact and Vaccine Prevention

There is important work to be done in raising awareness and providing education around the RSV disease state and the risks involved, especially to protect compromised groups. This interactive infographic delves into the severity of RSV, with a particular focus on patients who present with comorbidities such as COPD, asthma, and other underlying lung-related conditions.

Learning Objectives

  • Identify RSV pathophysiology
  • Describe risk factors, impact, and potential complications of RSV in older adults
  • Relate the importance of protecting older adults at risk for serious complications as a result of respiratory comorbidities
  • Prepare to implement new and emerging vaccines and illustrate their role in the prevention of RSV in adults

Supported by an independent medical educational grant from GSK

Advertisement